Chimerix Inc (CMRX) Options

CMRX...$8.44...🥳...https://finance.yahoo.com/news/jazz-pharmaceuticals-bids-chimerix-935m-180335162.html

CMRX....................................................................................p/m

CMRX, new 52 week high

CMRX new 52/week high

CMRX................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

cmrx...................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783

cmrx..................https://stockcharts.com/h-sc/ui?s=cmrx&p=W&b=5&g=0&id=p86431144783

CMRX.....bought in @ 2.93.....could see another leg up!

CMRX.........................................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

CMRX..............https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

$CMRX - Gain: 217% #DDAmanda Video Analysis - #1 Stock Screener / Scanner

#DDAmanda Christmas Special Signup:

https://ddamanda.com/SignUpXMAS.php

Questions/Support: 760 702-2009 - Hans@DDAmanda.com



Z

Congrat's to those those who had a good day here today.

CMRX: Another article about it ---
https://finance.yahoo.com/news/why-cancer-focused-chimerix-stock-143934294.html

CMRX...All out in the $3.10 range...🥳Beauty flip...from $2.02 range...

georgie18

Member Level
Re: georgie18 post# 667358

Tuesday, December 10, 2024 9:45:48 AM

Post#
667376
of 667379
CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

CMRX...$2.71...🥳...Volume...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 386753

Tuesday, December 10, 2024 8:14:24 AM

Post#
386761
of 386773
CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

CMRX...$2.37...🥳...Off my $2.02 Alert...

georgie18

Member Level
Re: georgie18 post# 667332

Monday, December 09, 2024 4:23:42 PM

Post#
667335
of 667357
CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

CMRX.............................https://stockcharts.com/h-sc/ui?s=CRMX&p=W&b=5&g=0&id=p86431144783

CMRX: Soaring!!! Likely $3-4 bucks in the Post-M!!!

CMRX.......................https://stockcharts.com/h-sc/ui?s=CMRX&p=W&b=5&g=0&id=p86431144783

CMRX...$2.22...🥳...

georgie18

Member Level
Re: None

Monday, December 09, 2024 4:21:32 PM

Post#
386753
of 386753
CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

CMRX...$2.02...🥳...DURHAM, N.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that, following extensive dialogue with the U.S. Food and Drug Administration (FDA), the Company plans to submit a complete New Drug Application (NDA) seeking accelerated approval for dordaviprone as a treatment for recurrent H3 K27M-mutant diffuse glioma in the United States before year-end.

⏰⏰⏰⏰⏰⏰⏰⏰⏰⏰

can this hold a buck if markets correct
or will they have to do something to maintain listing

💲CMRX

CMRX new 52 week low

GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:

GBIM
Globelmmune Inc (CE)
0.0002
0.00 (0.00%)
Volume:

CMRX new 52 low

CMRX new 52 week low

CMRX new 52 week low

Thanks, saw that but neglected to post news.

CMRX

https://www.businesswire.com/news/home/20221110005658/en/

More good news.

CMRX

News looks good.

CMRX

Nice news. Got some.

CMRX

WEEEEEEEEE

Monday fun here CMRX$ WOW! Monkey pox vaccine

$5 coming

Looking good

CMRX$

from the EBS earnings call transcript:

"
Unidentified Analyst

This is Nick on for Boris. So I just have a quick question about Chimerix and TEMBEXA. So previously, the -- right pretty much right after you guys announced this acquisition of TEMBEXA, they said that the BARDA contract was likely to take place within the next couple of weeks or months, and now it's pushed back. And I just wanted to know if you guys had any reasoning behind this or any information as to why it's been pushed back, especially with monkeypox and now being declared a public health emergency, you kind of think that it may be pushed forward, but it seems to be just pushed back a little bit more.

Bob Kramer

Yes. Thanks, Nick, for the question. Thanks for joining the call. So a couple of comments. As I commented on my prepared remarks, the HSR process and the waiting period for this expired last Friday. So now that, I think, gives BARDA and Chimerix kind of the green light to finalize the BARDA procurement agreement, which then gives us the clear path to closing the transaction and moving forward.

I wouldn't read anything into the perhaps perceived delay in getting the contract awarded. Obviously, BARDA is looking at this very carefully and they are aware that our interest in acquiring the product from Chimerix. So I think, again, there's momentum to get this done, and we're anxious to get done as well

"

my hope is that the BARDA negotiation is to 'upsize' the original contract that was discussed(?)

CMRX$$$$$$$$ WOOHOOOOOO

CMRX$ $5 TARGET

CMRX$Surfin USA

interesting if we get BARDA announcement this week; per last extension due 'soon'

CMRX - Nice news and nice pre market!

CMRX$

CMRX SIGA $$$$$$$$$$$$

CMRX$

Now we’re moving WOOHOOOOOO CMRX$$$$$$$$$$$$$$SIGA

CMRX SIGA Upchurch HI-DEAS 2 $$$$$$$$$$$